Close Menu

NEW YORK (GenomeWeb) – Recurrent translocations involving the immunoglobulin lambda (IgL) antibody locus may provide previously unappreciated clues to treatment response and patient outcomes in multiple myeloma, according to new research from an Emory University-led team.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.


This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.